TLDR: "Discontinuation of GLP-1RA treatment leads to weight regain, regardless of lifestyle interventions, and should therefore be considered a chronic therapy to prevent weight regain and associated undesirable outcomes related to obesity." Key findings: After stopping liraglutide, patients regained ~2.2 kg After stopping semaglutide/tirzepatide, patients regained ~9.7 kg Weight regain was proportional to initial weight loss Lifestyle changes alone DID NOT prevent regain Implication: GLP-1 receptor agonists are not a short-term solution
So once the quality of the product and testing are approved, the final marketing and distribution is done
Many seeking weight loss solutions in Santa Monica might wonder, "does insurance cover oral tirzepatide?" In reality, the lack of FDA approval precludes insurance coverage for compounded versions
This is how long your medication stays good after you've opened it and started using it
Our guide on restarting semaglutide provides relevant protocol guidance
We provide compounded injectable medication through a SCRIPT-certified pharmacy, with a personalized step-up dosing protocol designed to minimize side effects while maximizing your results
